Bisphosphonates and Age-Related Macular Degeneration: A Propensity-Matched Cohort and Nested Case-Control Analysis

Bisphosphonates and Age-Related Macular Degeneration: A Propensity-Matched Cohort and Nested Case-Control Analysis

Objective: To investigate the association between oral bisphosphonate (BP) use and the risk of developing age-related macular degeneration (AMD).

Dades bibliogràfiques
Autors principals:	Garriga, C, Judge, A, Hawley, S, Delmestri, A, Prieto-Alhambra, D, Cooper, C, Pazianas, M
Format:	Conference item
Publicat:	American Society for Bone and Mineral Research 2017

Ítems similars

Impact of bisphosphonates in age-related macular degeneration: Retrospective cohort and nested case-control study
per: Garriga, C, et al.
Publicat: (2018)

Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
per: Garriga, C, et al.
Publicat: (2018)

Impact of bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
per: Garriga, C, et al.
Publicat: (2018)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
per: Robinson, DE, et al.
Publicat: (2021)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
per: Robinson, DE, et al.
Publicat: (2021)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
per: Danielle E Robinson, et al.
Publicat: (2021-03-01)

The effects of disease-modifying antirheumatic drugs on dementia in patients with rheumatoid arthritis: a population-based propensity-matched cohort study over 15 years
per: Judge, A, et al.
Publicat: (2017)

Oral bisphosphonate use and latent class trajectories of kidney function: A cohort study
per: Strauss, V, et al.
Publicat: (2018)

Comparative risk of venous thromboembolism among users of different anti-osteoporosis drugs in the UK National Health Service and in Catalonia, Spain: A propensity-matched cohort study
per: Khalid, S, et al.
Publicat: (2017)

Comparative risk of acute myocardial infarction among users of different anti-osteoporosis drugs in Catalonia, Spain: A propensity matched cohort study using data from the SIDIAP database
per: Khalid, S, et al.
Publicat: (2017)

Comparative fracture risk amongst users of different anti-osteoporosis drugs available in the UK in the NHS: A propensity-matched cohort study using data from the Clinical Practice Research Datalink
per: Khalid, S, et al.
Publicat: (2016)

Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: A propensity score analysis
per: Prieto-Alhambra, D, et al.
Publicat: (2011)

Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis.
per: Prieto-Alhambra, D, et al.
Publicat: (2011)

Comparative risk of venous thromboembolism amongst users of different anti-osteoporosis drugs in the uk: a propensity-matched cohort study using data from the clinical practice research datalink
per: Khalid, S, et al.
Publicat: (2016)

Predictors of second fracture while on treatment with oral bisphosphonates: a multinational cohort study
per: Hawley, S, et al.
Publicat: (2014)

Comparative fracture risk amongst users of different anti-osteoporosis therapies: meta-analysis of propensity-matched cohort studies using data from the Clinical Practice Research Datalink (UK) and SIDIAP (Spain).
per: Khalid, S, et al.
Publicat: (2017)

Reduction in fracture rates with Denosumab compared to Alendronate in treatment naïve patients: a propensity-matched ‘real world’ cohort and instrumental variable analysis.
per: Khalid, S, et al.
Publicat: (2017)

The association between calcium ± vitamin D supplementation and fracture risk among incident users of oral bisphosphonates: a population-based cohort study
per: Reyes, C, et al.
Publicat: (2015)

Predictors of fracture while on treatment with oral bisphosphonates: a population-based cohort study.
per: Prieto-Alhambra, D, et al.
Publicat: (2014)

BISPHOSPHONATE USE IS ASSOCIATED WITH REDUCED REVISIONS OF LOWER LIMB JOINT (KNEE OR HIP) ARTHROPLASTY: A POPULATION-BASED COHORT STUDY
per: Prieto-Alhambra, D, et al.
Publicat: (2011)

Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on “real-world” data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database
per: Khalid, S, et al.
Publicat: (2018)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study.
per: Prieto-Alhambra, D, et al.
Publicat: (2011)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study.
per: Prieto-Alhambra, D, et al.
Publicat: (2011)

Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database
per: Khalid, S, et al.
Publicat: (2022)

Oral bisphosphonate use and risk of acute kidney injury, gastrointestinal events and hypocalcaemia in patients with moderate-advanced chronic kidney disease: a population-based cohort study
per: Ali, MS, et al.
Publicat: (2017)

Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on “real-world” data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database
per: Khalid S, et al.
Publicat: (2018-10-01)

Oral bisphosphonate use and all‐cause mortality in patients with advanced (stage IIIB+) chronic kidney disease: a propensity score analysis
per: Alarkawi, D, et al.
Publicat: (2018)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: Population based retrospective cohort study
per: Prieto-Alhambra, D, et al.
Publicat: (2012)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: Population based retrospective cohort study
per: Prieto-Alhambra, D, et al.
Publicat: (2012)

Descriptive epidemiology of hip and knee replacement among rheumatoid arthritis patients in England and Wales: variation by age, sex, geography and socioeconomic status
per: Hawley, S, et al.
Publicat: (2017)

Total hip and knee replacement among incident osteoarthritis and rheumatoid arthritis patients within the UK Clinical Practice Research Datalink (CPRD) compared to hospital episode statistics (HES): a validation study
per: Hawley, S, et al.
Publicat: (2016)

Descriptive epidemiology of hip and knee replacement in rheumatoid arthritis: an analysis of UK electronic medical records
per: Hawley, S, et al.
Publicat: (2019)

Imminent fracture risk amongst new users of oral bisphosphonates in actual practice settings: A multi-national European cohort study from Denmark, Spain, and the UK
per: Khalid, S, et al.
Publicat: (2019)

Anti-osteoporosis medication prescriptions and incidence of secondary fracture amongst hip fracture patients in England and Wales: an age stratified interrupted time series analysis
per: Hawley, S, et al.
Publicat: (2018)

A PREDICTIVE TOOL FOR ORAL BISPHOSPHONATE THERAPY DISCONTINUATION WITHIN INCIDENT USERS: A POPULATION-BASED COHORT STUDY
per: Round, G, et al.
Publicat: (2012)

Negative control time window to identify residual confounding in comparative effectiveness study: An example of bisphosphonate use and risk of fracture
per: Robinson, D, et al.
Publicat: (2018)

Use of oral bisphosphonates and bone mineral density changes in moderate-severe (Stage 3B+) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark
per: Ali, M, et al.
Publicat: (2017)

Comparative effectiveness of tumour necrosis factor inhibitor therapy vs. conventional synthetic dmards on need for joint replacement among rheumatoid arthritis patients: A propensity score matched analysis of UK registry data
per: Hawley, S, et al.
Publicat: (2018)

Safety of bisphosphonates.
per: Pazianas, M, et al.
Publicat: (2011)

Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis
per: Robinson, DE, et al.
Publicat: (2021)